{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-041133","form_type":"8-K","ticker":"IMDX","cik":"0001642380","company_name":"Insight Molecular Diagnostics Inc.","filed_at":"2024-10-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.077281+00:00","generated_at":"2026-05-30T14:36:32.368277+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Oncocyte shareholders approve 1.25M share increase to equity plan","bullets":["Stockholders approved Amended and Restated 2018 Equity Incentive Plan adding 1,250,000 shares, total pool now 2,300,000 shares.","Vote: 8,469,172 for, 110,188 against, 8,410 abstained; 64.21% of voting power represented at special meeting on Oct 11, 2024.","Amendments remove fungible share counting, eliminate share recycling restrictions, and remove one-year vesting minimum.","Plan authorizes delegation of award grants to executive officers under Board-established limits."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-041133","json":"https://secwatch.observer/filing/0001493152-24-041133.json","markdown":"https://secwatch.observer/filing/0001493152-24-041133.md","text":"https://secwatch.observer/filing/0001493152-24-041133.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1642380/000149315224041133/0001493152-24-041133-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1642380/000149315224041133/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T14:36:32.368277+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}